Literature DB >> 33157089

Effects of dietary patterns combined with dietary phytochemicals on breast cancer metastasis.

Shuxue Pang1, Min Jia1, Jianxin Gao1, Xiaoyu Liu1, Wenhui Guo1, Hongyan Zhang2.   

Abstract

AIMS: Dietary phytochemicals and diet types (e.g., the Mediterranean diet) have been shown to have anti-cancer properties. However, the effects of combined treatment with dietary phytochemicals and different diet types on primary and metastatic tumor growth have yet to be investigated. The purpose of this study is to investigate the effects of phytochemicals combined with diet types on breast cancer metastasis. MAIN
METHODS: The inhibitory effects on breast cancer metastasis of three phytochemicals (allicin, hesperidin, astragalus polysaccharides) and two diet types (Mediterranean diet, restricted diet), separately or in combination, were evaluated based on: (i) detection of circulating tumor cells (CTCs) using an in vivo capture method; and (ii) primary tumor growth. KEY
FINDINGS: All dietary factors significantly inhibited the growth of primary tumors and metastases, with combinations showing enhancing the effects. SIGNIFICANCE: Dietary phytochemicals and diet types should be further evaluated as adjunct therapies and lifestyle modifications in cancer patients. Furthermore, the in vivo CTC capture method allows dynamic monitoring of cancer metastasis over time, providing a useful approach to evaluating treatment effects in real-time.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Cancer metastasis; Circulating tumor cells; Combined therapy; Dietary patterns; Dietary phytochemicals

Mesh:

Substances:

Year:  2020        PMID: 33157089     DOI: 10.1016/j.lfs.2020.118720

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  1 in total

1.  Chondroitin Sulfate-Modified Liposomes for Targeted Co-Delivery of Doxorubicin and Retinoic Acid to Suppress Breast Cancer Lung Metastasis.

Authors:  Zhiwei Zhang; Lixin Ma; Jingwen Luo
Journal:  Pharmaceutics       Date:  2021-03-19       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.